SUBSCRIBE
SUBSCRIBE
News   Policy

Johnson & Johnson Plant in Merck & Co., Inc. Venture Cited by U.S. FDA

July 20, 2010 | 
1 min read
Reuters -- Johnson & Johnson (JNJ.N) has been cited by U.S. regulators for problems at a plant that is part of a consumer medicines joint venture with Merck & Co Inc (MRK.N), in a fresh blow to its manufacturing operations.
Regulatory
Johnson & Johnson Family of Companies Merck & Co. Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Vaccine and syringe injection. Doctor hand with syringe. Vaccination of people for prevention, immunization and treatment from virus infection. Medicine, flu shot, test with needle. Vector
Adcomms
Moderna’s once-rebuffed mRNA flu shot to face scrutiny from FDA adcomm
May 22, 2026
 · 
2 min read
 · 
Tristan Manalac
Richard Pazdur
Regulatory
Pazdur declines to announce candidacy for vacated FDA commissioner role
May 20, 2026
 · 
4 min read
 · 
Heather McKenzie
FDA
FDA’s absent leaders, the millions pharma CEOs make, and pancreatic cancer’s momentum
May 20, 2026
 · 
1 min read
 · 
Jef Akst
The COVID-19 vaccine in glass bottles for prevention, immunization, and treatment of coronavirus infection on a green background. Space for text. Concept of medical and vaccine.
COVID-19
FDA’s own report shows no child deaths definitively caused by COVID vaccination
May 19, 2026
 · 
3 min read
 · 
Tristan Manalac